Andrew Jackson - Aug 21, 2025 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Role
Chief Financial Officer
Signature
/s/ Andrew Jackson
Stock symbol
CLDI
Transactions as of
Aug 21, 2025
Transactions value $
$5,000
Form type
4
Date filed
8/25/2025, 08:47 PM
Previous filing
Jun 20, 2024
Next filing
Sep 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jackson Andrew C. Chief Financial Officer C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, /s/ Andrew Jackson 2025-08-25 0001636738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDI Common Stock Purchase $5K +2.5K $2.00 2.5K Aug 21, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDI Warrant (right to buy) Purchase +2.5K 2.5K Aug 21, 2025 Common stock 2.5K $2.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
F2 Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.